IDiyas

For the Inventor, By the Inventor

Essex, CT, United States of America

Bernard Hulin

USPTO Granted Patents = 23

Average Co-Inventor Count = 2.1

ph-index = 14

Forward Citations = 439(Granted Patents)


Location History:

  • Groton, CT (US) (1992 - 1993)
  • Essex, CT (US) (1991 - 2008)

Company Filing History:

goldMedal23 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1991-2008

Loading Chart...
23 patents (USPTO):Explore Patents
1. 7465732 - (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives (2008-12-16),
2. 7291618 - Therapeutic compounds (2007-11-06),
3. 6846820 - Substituted N-(indole-2-carbonyl) -amides and derivatives as glycogen phosphorylase inhibitors (2005-01-25),
4. 6812350 - Synthesis of 3,3,4,4-tetrafluoropyrrolidine and novel dipeptidyl peptidase-IV inhibitor compounds (2004-11-02),
5. 6710040 - Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors (2004-03-23),
6. 6649634 - Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors (2003-11-18),
7. 6541495 - Carboxylic acid derivatives as inhibitors of hyperproliferation diseases (2003-04-01),
8. 6297269 - Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors (2001-10-02),
9. 6277877 - Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors (2001-08-21),
10. 6107329 - Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as (2000-08-22),
11. 5998463 - Glycogen phosphorylase inhibitors (1999-12-07),
12. 5498621 - Oxazolidinedione hypoglycemic agents (1996-03-12),
13. 5438074 - 3-aryl-2-hydroxypropionic acid derivatives and analogs as hypoglycemic (1995-08-01),
14. 5401761 - Thiazolidinedione hypoglycemic agents (1995-03-28),
15. 5330998 - Thiazolidinedione derivatives as hypoglycemic agents (1994-07-19),

Certainly! Here is the article about inventor Bernard Hulin:

Title: Inventor Spotlight: Bernard Hulin

Introduction:

Bernard Hulin is a prolific inventor based in Essex, CT, with a remarkable track record in the field of pharmaceutical innovation. With a total of 23 patents to his name, Bernard Hulin has made significant contributions to the healthcare industry through his groundbreaking discoveries.

Latest Patents:

1. (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives: Bernard Hulin's invention provides compounds with potential in treating Type 2 diabetes. These compounds offer promising therapeutic benefits, opening new avenues for diabetic patients.

2. Therapeutic compounds: Hulin's invention involves compounds, prodrugs, and stereoisomers that show promise in treating diabetic complications such as neuropathy, nephropathy, and microangiopathy. This innovation underscores his dedication to advancing healthcare solutions.

Career Highlights:

Bernard Hulin is a valued member of Pfizer Corporation, a renowned pharmaceutical company known for its groundbreaking research and development efforts. His expertise and innovative mindset align perfectly with Pfizer's commitment to addressing global health challenges through pioneering pharmaceutical solutions.

Collaborations:

Throughout his career, Bernard Hulin has collaborated with esteemed professionals in the field. Notable coworkers include Steven Wayne Goldstein and David A. Clark, whose combined expertise has further enriched the innovative projects led by Hulin.

Conclusion:

Bernard Hulin's exceptional work in pharmaceutical innovation, as evidenced by his extensive patent portfolio, exemplifies his dedication to improving healthcare outcomes. His contributions to the development of novel therapeutic compounds for diabetic patients reflect a commitment to advancing medical science and enhancing quality of life.

Is there anything else you would like to know about Bernard Hulin or any other inventor?

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…